Acquired intestinal lymphangiectasia successfully treated with a low-fat and medium-chain triacylglycerol-enriched diet in a patient with liver transplantation

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 5, 2006, Pages 561-564

  Biselli, Maurizio ^a   Andreone, Pietro ^a,b   Gramenzi, Annagiulia ^a   Cursaro, Carmela ^a   Lorenzini, Stefania ^a   Bonvicini, Fiorenza ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Ascites; Cirrhosis; Enteric protein loss; Liver transplant

Indexed keywords

ALBUMIN; CARBOHYDRATE; DIURETIC AGENT; FUROSEMIDE; LIPID; MEDIUM CHAIN TRIACYLGLYCEROL; PROTEIN; SPIRONOLACTONE;

ABDOMINAL RADIOGRAPHY; ADULT; ALBUMIN BLOOD LEVEL; ANAMNESIS; ARTICLE; ASCITES; CASE REPORT; CHRONIC GASTRITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DUODENUM BIOPSY; ESOPHAGUS VARICES; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HUMAN; HYPOALBUMINEMIA; HYPOPROTEINEMIA; INTESTINE BIOPSY; INTESTINE LYMPHANGIECTASIA; INTESTINE VILLUS; LABORATORY TEST; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOW FAT DIET; LYMPH VESSEL; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; LYMPHOCYTOPENIA; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; RECURRENT DISEASE; SPLENOMEGALY; TREATMENT INDICATION; TREATMENT OUTCOME;

DIET, FAT-RESTRICTED; DUODENUM; HEPATITIS C; HUMANS; INTESTINAL MUCOSA; LIVER TRANSPLANTATION; LYMPHANGIECTASIS, INTESTINAL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTEIN-LOSING ENTEROPATHIES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33744819469     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200605000-00020     Document Type: Article

References (11)

1. Strober W, Wochner RD, Carbone PP, Waldmann TA. Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest 1967; 46:1643-1656.
2. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
3. Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol 1997; 37:523-549.
4. Miura S, Asakura H, Munakata Y, Kobayashi K, Yoshioka M, Morishita T, et al. Lymphatic role in the pathogenesis of fat malabsorption in liver cirrhosis in rats. Dig Dis Sci 1982; 27:1030-1036.
5. Llovet JM, Batoli R, Planas R, Viñado B, Perez J, Cabré E, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 1996; 23:781-787.
6. Teixeira R, Pastacaldi S, Papatheodoridis GV, Burroughs AK. Recurrent hepatitis C after liver transplantation. J Med Virol 2000; 61:443-454.
7. Vierling JM, Villamil FG, Rojter SE, Camacho KB, Goldman DE. Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation. J Viral Hepat 1997; 4 (suppl 1):117-124.
8. Witte CL, Witte MH, Dumont AE. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 1980; 78:1059-1068.
9. Dumont AE, Mulholland JH. Alterations in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann Surg 1962; 156:668-677.
10. Garcia-Doval I, de laTorre C, Losada A, Ocampo C, Rodriguez T, Crucis MJ. Acquired cutaneous lymphangiectasia in a patient with cirrhotic ascites. J Eur Acad Dermatol Venereol 1999; 13:109-112.
11. Tift WL, Lloyd JK. Intestinal lymphangiectasia. Long-term results with MCT diet. Arch Dis Child 1975; 50:269-276.